Author: Julia

Kudos to everyone who helped make the 2nd Annual Glomerular Disease Symposium: An Update on Disease Mechanisms and Management, held September 6 – 7, 2024, a success.  The event was organized and chaired by WashU Nephrology’s Tingting Li, MD, MSCI, with the support of the planning committee members Michelle Bloom, BSN, RN, Reena Gurung, MD, Nidia Messias, MD, and Morgan Schoer, MD, and Continuing Medical […]

In March, Alexander M. Markov, MD; Sina Jasim, MD, MPH; and Jennifer Powers Carson, PhD had their article titled “A Puzzling Case of Elevated Parathyroid Hormone,” published by The Journal of Applied Laboratory Medicine.

Having a severe case of Covid-19 appears to be linked with an increased risk of subsequent mental illness, including depression and anxiety disorders, and a new study finds that the association is strongest among people who were not vaccinated against the disease.

Assistant Professor of Medicine Dr. Ali Javaheri was featured in an article titled “Translating metabolic and cardiovascular research into effective treatments: What’s next?” In a special 50th Anniversary edition of the journal Cell.

Healthcare innovation is accelerating at an unprecedented pace, and cardiology is on the brink of transformative change using new forms of remote monitoring and artificial intelligence (AI). 

Researchers at Washington University School of Medicine in St. Louis have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer. Only 5% of patients survive five years after diagnosis with the most aggressive brain cancers.  

Raja Dandamudi, MD, an assistant professor of pediatrics, Vikas Dharnidharka, MD, a professor of pediatrics, and Tarek Alhamad, MD, a professor of medicine at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection. The international team found that DNA shed from dying […]

Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells — cells that have stopped dividing and drive inflammation — may play important roles in suppressing the immune system and allowing such tumors to grow unchecked. 

The Society of Hospital Medicine has several publications, including their monthly newsletter, ‘The Hospitalist.’ For the month of August 2024, Dr. Mark Williams was featured on the cover of the newsletter, and was interviewed for an article titled, “Managing the Long-term Physical Effects of Being a Hospitalist.”

Study in hamsters indicates vaccines targeting nose, mouth may be key to controlling spread of respiratory infections

Marlie Maestas, a fifth-year graduate student in the Millman Lab, recently published her first first-authorship in Nature Communications. The study, titled Identification of unique cell type responses in pancreatic islets to stress, detailed the responses of different pancreatic islet cell types to endoplasmic reticulum and inflammatory stress.

DOLF investigators are beginning a follow-up study on the efficacy of a new combination treatment for lymphatic filariasis (LF) and onchocerciasis in the Akoupé district of Côte d’Ivoire. This study began July 4th and builds upon a large-scale community survey sponsored by Medicines Development for Global Health (MDGH).

St. Louis-based center unites scientists, public health experts, nonprofits to fight virus

“Heavy and healthy” can be a rare or common condition. But either way it may signal that some excess weight is just fine.

Associate Professor of Medicine and Associate Director of the Wash U Hypertrophic Cardiomyopathy Center, Dr. Sharon Cresci is Vice-Chair on a new statement published this week in the journal Circulation on behalf of the American Heart Association.

Center will support new collaborations, infrastructure to accelerate precision medicine

Congratulations to first-year fellow Susrutha Puthanmadhom Narayanan, MBBS, who presented her research at ASCO 2024 this past weekend entitled, “Transcriptomic Analysis of cAMP/PKA/CREB Signaling in Invasive Lobular Breast Cancer”. 

Artificial intelligence—the next wave of technology— is emerging in many ways in medical practices and health systems in the St. Louis area.

Genetically engineered B cells could produce super-antibodies to HIV